CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 152 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $51,365,393 | +72.7% | 1,336,934 | +4.1% | 0.02% | +60.0% |
Q1 2023 | $29,736,498 | +91574.6% | 1,284,521 | +3.8% | 0.01% | 0.0% |
Q4 2022 | $32,437 | -99.9% | 1,238,080 | +11.2% | 0.01% | +25.0% |
Q3 2022 | $21,895,000 | +50.4% | 1,113,744 | +33.8% | 0.01% | +60.0% |
Q2 2022 | $14,559,000 | +71.0% | 832,406 | +59.9% | 0.01% | +66.7% |
Q1 2022 | $8,515,000 | +78.9% | 520,475 | +78.3% | 0.00% | +200.0% |
Q4 2021 | $4,760,000 | +81.3% | 291,835 | +41.8% | 0.00% | 0.0% |
Q3 2021 | $2,625,000 | +92.4% | 205,783 | +113.0% | 0.00% | – |
Q2 2021 | $1,364,000 | +558.9% | 96,606 | +626.1% | 0.00% | – |
Q1 2021 | $207,000 | -84.4% | 13,304 | -84.1% | 0.00% | – |
Q4 2020 | $1,328,000 | – | 83,698 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 5,161,888 | $198,319,737 | 34.81% |
Saturn V Capital Management LP | 524,811 | $20,163,239 | 11.18% |
Frazier Life Sciences Management, L.P. | 4,345,559 | $166,956,377 | 9.97% |
Altium Capital Management LP | 305,000 | $11,718,100 | 8.87% |
MPM BioImpact LLC | 1,003,406 | $38,550,859 | 7.76% |
Affinity Asset Advisors, LLC | 321,017 | $12,333,473 | 4.31% |
ALPINE ASSOCIATES MANAGEMENT INC. | 2,131,000 | $81,873,020 | 3.69% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,748,141 | $67,163,577 | 3.59% |
Nan Fung Group Holdings Ltd | 113,950 | $4,377,959 | 2.80% |
Vivo Capital, LLC | 934,879 | $35,918,051 | 2.48% |